Bartlett & Co’s Elevance Health ELV Stock Holding History

Bartlett & Co’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.67M	Buy	3,565 +99	+3%	+$45.8K	0.03%	217
2023 Q3	$1.51M	Hold	3,466	–	–	0.03%	219
2023 Q2	$1.54M	Buy	3,466 +2,515	+264%	+$1.16M	0.03%	224
2023 Q1	$437K	Hold	951	–	–	0.01%	299
2022 Q4	$488K	Sell	951 -4	-0.4%	-$2.03K	0.01%	294
2022 Q3	$434K	Sell	955 -7	-0.7%	-$3.35K	0.01%	298
2022 Q2	$464K	Buy	962 +11	+1%	+$5.44K	0.01%	289
2022 Q1	$467K	Hold	951	–	–	0.01%	299
2021 Q4	$441K	Hold	951	–	–	0.01%	309
2021 Q3	$355K	Sell	951 -56	-6%	-$21.3K	0.01%	288
2021 Q2	$384K	Hold	1,007	–	–	0.01%	280
2021 Q1	$361K	Hold	1,007	–	–	0.01%	284
2020 Q4	$323K	Buy	1,007 +6	+0.6%	+$1.84K	0.01%	287
2020 Q3	$269K	Hold	1,001	–	–	0.01%	284
2020 Q2	$263K	Buy	1,001 +49	+5%	+$13.1K	0.01%	283
2020 Q1	$216K	Buy	+952	New	+$259K	0.01%	289
2019 Q3	$229K	Buy	952 +90	+10%	+$24.7K	0.01%	312
2019 Q2	$243K	Buy	862 +1	+0.1%	+$273	0.01%	244
2019 Q1	$247K	Hold	861	–	–	0.01%	242
2018 Q4	$226K	Hold	861	–	–	0.01%	242
2018 Q3	$236K	Buy	861 +74	+9%	+$19.2K	0.01%	243
2018 Q2	$187K	Hold	787	–	–	0.01%	258
2018 Q1	$173K	Hold	787	–	–	0.01%	261
2017 Q4	$177K	Buy	787 +264	+50%	+$56.2K	0.01%	266
2017 Q3	$99K	Hold	523	–	–	﹤0.01%	322
2017 Q2	$98K	Sell	523 -350	-40%	-$62.9K	﹤0.01%	317
2017 Q1	$144K	Hold	873	–	–	0.01%	283
2016 Q4	$126K	Hold	873	–	–	0.01%	294
2016 Q3	$109K	Hold	873	–	–	0.01%	307
2016 Q2	$115K	Hold	873	–	–	0.01%	301
2016 Q1	$121K	Hold	873	–	–	0.01%	293
2015 Q4	$122K	Hold	873	–	–	0.01%	301
2015 Q3	$122K	Hold	873	–	–	0.01%	291
2015 Q2	$143K	Hold	873	–	–	0.01%	292
2015 Q1	$135K	Sell	873 -26	-3%	-$3.7K	0.01%	293
2014 Q4	$113K	Sell	899 -13	-1%	-$1.61K	0.01%	310
2014 Q3	$109K	Sell	912 -45	-5%	-$5.16K	0.01%	301
2014 Q2	$103K	Sell	957 -235	-20%	-$24.2K	0.01%	307
2014 Q1	$119K	Sell	1,192 -67	-5%	-$6.06K	0.01%	289
2013 Q4	$116K	Sell	1,259 -13	-1%	-$1.16K	0.01%	288
2013 Q3	$106K	Hold	1,272	–	–	0.01%	292
2013 Q2	$104K	Buy	+1,272	New	+$95.2K	0.01%	288

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bartlett & Co's ELV Position: Q4 2023 in Review

Bartlett & Co increased its Elevance Health (ELV) stake by 2.9% in Q4 2023, buying an estimated $45.8K and bringing the position to 3,565 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #217.

Bartlett & Co first reported a position in ELV in Q2 2013 and has held it in 42 quarters since. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Bartlett & Co held 3,565 shares of Elevance Health worth $1.67M as of Q4 2023.
Bartlett & Co bought 99 Elevance Health shares in Q4 2023, an estimated $45.8K.
Elevance Health made up 0.03% of Bartlett & Co's portfolio in Q4 2023, its #217 holding.
Bartlett & Co first reported a position in Elevance Health in Q2 2013 and has held it in 42 quarters since.
1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.